3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
12
Lymphoma, Large B-Cell, Diffuse
12
Sarcoma, Ewing
4
Lymphoma, B-Cell
4
Recurrence
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Osteosarcoma
3
Neurofibrosarcoma
3
Lymphoma, Non-Hodgkin
3
Liposarcoma
3
Hodgkin Disease
3
Fibrosarcoma
3
Sarcoma, Synovial
2
Sarcoma, Clear Cell
2
Rhabdomyosarcoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroblastoma
2
Nerve Sheath Neoplasms
2
Neoplasms, Germ Cell and Embryonal
2
Lymphoma, Follicular
2
Lymphoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Histiocytoma, Angiomatoid Fibrous
2
Hemangiosarcoma
2
Granuloma, Plasma Cell
2
Desmoplastic Small Round Cell Tumor
2
Dermatofibrosarcoma
2
Chondrosarcoma, Extraskeletal Myxoid
2
Burkitt Lymphoma
2
Interventions
Nivolumab
3
capivasertib
2
Gemcitabine
2
Cisplatin
2
tivozanib
1
regorafenib
1
niraparib
1
neratinib
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
fludarabine
1
encorafenib
1
durvalumab
1
copanlisib
1
cemiplimab
1
axicabtagene ciloleucel
1
avasopasem manganese
1
Valproic Acid
1
Thioctic Acid
1
Taxes
1
Receptors, Interleukin-6
1
Radiosurgery
1
RNA-Seq
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Multiparametric Magnetic Resonance Imaging
1
Leucovorin
1
Lenalidomide
1
Interleukin 1 Receptor Antagonist Protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease Progression
×
Ifosfamide
×
1 year
×
Clear all
No trials found.